Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TYRA is expected to report earnings to rise 8.60% to -51 cents per share on October 30
Q3'25
Est.
$-0.51
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.01
The last earnings report on August 14 showed earnings per share of -46 cents, beating the estimate of -52 cents. With 214.84K shares outstanding, the current market capitalization sits at 673.68M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TYRA showed earnings on August 14, 2025. You can read more about the earnings report here.